Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Kimbell Royalty Partners
KRP
$1.51B
| $226K | ﹤0.01% |
16,125
-171,546
| -91% | -$2.59M |
|
3877
Biote Corp
BTMD
$43.3M
| $226K | ﹤0.01% |
67,749
-9,629
| -12% | -$45.9K |
|
3878
Compass Therapeutics
CMPX
$418M
| $226K | ﹤0.01% |
118,731
-74,035
| -38% | -$197K |
|
3879
Eagle Bancorp Montana
EBMT
$187M
| $225K | ﹤0.01% |
13,441
-1,317
| -9% | -$21.4K |
|
3880
Aehr Test Systems
AEHR
$4.09B
| $225K | ﹤0.01% |
30,807
-14,098
| -31% | -$156K |
|
3881
Solid Biosciences
SLDB
$978M
| $225K | ﹤0.01% |
60,691
+6,131
| +11% | +$26.3K |
|
3882
AtaiBeckley Inc
ATAI
$2.68B
| $224K | ﹤0.01% |
164,964
-5
| -0% | -$8 |
|
3883
Mistras Group
MG
$561M
| $224K | ﹤0.01% |
21,181
-18,525
| -47% | -$183K |
|
3884
MBIA
MBI
$255M
| $223K | ﹤0.01% |
44,842
-73,669
| -62% | -$456K |
|
3885
Genie Energy
GNE
$386M
| $223K | ﹤0.01% |
14,805
-8,442
| -36% | -$123K |
|
3886
Ocugen
OCGN
$468M
| $222K | ﹤0.01% |
314,288
-139,127
| -31% | -$96.2K |
|
3887
Aviat Networks
AVNW
$284M
| $222K | ﹤0.01% |
11,572
-5,916
| -34% | -$120K |
|
3888
SmartRent
SMRT
$287M
| $222K | ﹤0.01% |
183,246
-104,182
| -36% | -$146K |
|
3889
PUT
Charter Communications
CHTR
$18.1B
| $221K | ﹤0.01% |
600
-3,500
| -85% | -$1.25M |
|
3890
Savers
SVV
$1.69B
| $219K | ﹤0.01% |
31,784
-20,478
| -39% | -$189K |
|
3891
Pure Cycle
PCYO
$277M
| $219K | ﹤0.01% |
20,943
-10,304
| -33% | -$117K |
|
3892
Alvotech
ALVO
$1.33B
| $219K | ﹤0.01% |
22,667
+6,807
| +43% | +$82.6K |
|
3893
Vanguard Morningstar Small-Cap ETF
VB
$83.2B
| $219K | ﹤0.01% |
988
| – | – |
|
3894
iShares Expanded Tech Sector ETF
IGM
$11B
| $218K | ﹤0.01% |
2,400
+1,200
| +100% | +$121K |
|
3895
Arteris
AIP
$1.39B
| $217K | ﹤0.01% |
31,406
-13,317
| -30% | -$127K |
|
|
MCHB
3896
Mechanics Bancorp
MCHB
$3.8B
| $216K | ﹤0.01% |
18,383
-9,148
| -33% | -$90.7K |
|
|
TEN
3897
Tsakos Energy Navigation Ltd
TEN
$1.24B
| $215K | ﹤0.01% |
12,578
+12,309
| +4,576% | +$214K |
|
3898
Alico
ALCO
$307M
| $215K | ﹤0.01% |
7,190
-3,496
| -33% | -$104K |
|
3899
Inspired Entertainment
INSE
$163M
| $214K | ﹤0.01% |
25,110
-10,722
| -30% | -$103K |
|
3900
Monte Rosa Therapeutics
GLUE
$1.37B
| $214K | ﹤0.01% |
46,210
-24,531
| -35% | -$150K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.